ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lung AI-assisted Diagnosis Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-7A17456
Home | Market Reports | Health
Global Lung AI assisted Diagnosis Solution Market Research Report 2024
BUY CHAPTERS

Global Lung AI-assisted Diagnosis Solution Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-7A17456
Report
November 2025
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sense Time
United-imaging
Huiying Medical
Yizhun
BioMind
Shukun
Infervision
Deepwise
Optellum
IMLINCS
NeuMiva
VoxelCloud

Lung AI-assisted Diagnosis Solution Market

The global Lung AI-assisted Diagnosis Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Lung AI-assisted Diagnosis Solution leading manufacturers including Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Infervision, Deepwise, Optellum, IMLINCS, etc., dominate supply; the top five capture approximately % of global revenue, with Sense Time leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Lung AI-assisted Diagnosis Solution market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Lung AI-assisted Diagnosis Solution Market Report

Report Metric Details
Report Name Lung AI-assisted Diagnosis Solution Market
Segment by Type
  • Public Cloud
  • Private Cloud
Segment by Application
  • Hospital
  • Clinic
  • Imaging Center
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Infervision, Deepwise, Optellum, IMLINCS, NeuMiva, VoxelCloud
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Lung AI-assisted Diagnosis Solution study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Lung AI-assisted Diagnosis Solution Market report?

Ans: The main players in the Lung AI-assisted Diagnosis Solution Market are Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Infervision, Deepwise, Optellum, IMLINCS, NeuMiva, VoxelCloud

What are the Application segmentation covered in the Lung AI-assisted Diagnosis Solution Market report?

Ans: The Applications covered in the Lung AI-assisted Diagnosis Solution Market report are Hospital, Clinic, Imaging Center

What are the Type segmentation covered in the Lung AI-assisted Diagnosis Solution Market report?

Ans: The Types covered in the Lung AI-assisted Diagnosis Solution Market report are Public Cloud, Private Cloud

1 Study Coverage
1.1 Introduction to Lung AI-assisted Diagnosis Solution: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Lung AI-assisted Diagnosis Solution Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Public Cloud
1.2.3 Private Cloud
1.3 Market Segmentation by Application
1.3.1 Global Lung AI-assisted Diagnosis Solution Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Imaging Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lung AI-assisted Diagnosis Solution Revenue Estimates and Forecasts 2020-2031
2.2 Global Lung AI-assisted Diagnosis Solution Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Lung AI-assisted Diagnosis Solution Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Lung AI-assisted Diagnosis Solution Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Public Cloud Market Size by Players
3.3.2 Private Cloud Market Size by Players
3.4 Global Lung AI-assisted Diagnosis Solution Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Lung AI-assisted Diagnosis Solution Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Lung AI-assisted Diagnosis Solution Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Lung AI-assisted Diagnosis Solution Market Size by Type (2020-2031)
6.4 North America Lung AI-assisted Diagnosis Solution Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Lung AI-assisted Diagnosis Solution Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Lung AI-assisted Diagnosis Solution Market Size by Type (2020-2031)
7.4 Europe Lung AI-assisted Diagnosis Solution Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Lung AI-assisted Diagnosis Solution Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Lung AI-assisted Diagnosis Solution Market Size by Type (2020-2031)
8.4 Asia-Pacific Lung AI-assisted Diagnosis Solution Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Lung AI-assisted Diagnosis Solution Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Lung AI-assisted Diagnosis Solution Market Size by Type (2020-2031)
9.4 Central and South America Lung AI-assisted Diagnosis Solution Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Lung AI-assisted Diagnosis Solution Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Lung AI-assisted Diagnosis Solution Market Size by Type (2020-2031)
10.4 Middle East and Africa Lung AI-assisted Diagnosis Solution Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Lung AI-assisted Diagnosis Solution Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sense Time
11.1.1 Sense Time Corporation Information
11.1.2 Sense Time Business Overview
11.1.3 Sense Time Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.1.4 Sense Time Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.1.5 Sense Time Lung AI-assisted Diagnosis Solution Revenue by Product in 2024
11.1.6 Sense Time Lung AI-assisted Diagnosis Solution Revenue by Application in 2024
11.1.7 Sense Time Lung AI-assisted Diagnosis Solution Revenue by Geographic Area in 2024
11.1.8 Sense Time Lung AI-assisted Diagnosis Solution SWOT Analysis
11.1.9 Sense Time Recent Developments
11.2 United Imaging
11.2.1 United Imaging Corporation Information
11.2.2 United Imaging Business Overview
11.2.3 United Imaging Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.2.4 United Imaging Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.2.5 United Imaging Lung AI-assisted Diagnosis Solution Revenue by Product in 2024
11.2.6 United Imaging Lung AI-assisted Diagnosis Solution Revenue by Application in 2024
11.2.7 United Imaging Lung AI-assisted Diagnosis Solution Revenue by Geographic Area in 2024
11.2.8 United Imaging Lung AI-assisted Diagnosis Solution SWOT Analysis
11.2.9 United Imaging Recent Developments
11.3 Huiying Medical
11.3.1 Huiying Medical Corporation Information
11.3.2 Huiying Medical Business Overview
11.3.3 Huiying Medical Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.3.4 Huiying Medical Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.3.5 Huiying Medical Lung AI-assisted Diagnosis Solution Revenue by Product in 2024
11.3.6 Huiying Medical Lung AI-assisted Diagnosis Solution Revenue by Application in 2024
11.3.7 Huiying Medical Lung AI-assisted Diagnosis Solution Revenue by Geographic Area in 2024
11.3.8 Huiying Medical Lung AI-assisted Diagnosis Solution SWOT Analysis
11.3.9 Huiying Medical Recent Developments
11.4 Yizhun
11.4.1 Yizhun Corporation Information
11.4.2 Yizhun Business Overview
11.4.3 Yizhun Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.4.4 Yizhun Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.4.5 Yizhun Lung AI-assisted Diagnosis Solution Revenue by Product in 2024
11.4.6 Yizhun Lung AI-assisted Diagnosis Solution Revenue by Application in 2024
11.4.7 Yizhun Lung AI-assisted Diagnosis Solution Revenue by Geographic Area in 2024
11.4.8 Yizhun Lung AI-assisted Diagnosis Solution SWOT Analysis
11.4.9 Yizhun Recent Developments
11.5 BioMind
11.5.1 BioMind Corporation Information
11.5.2 BioMind Business Overview
11.5.3 BioMind Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.5.4 BioMind Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.5.5 BioMind Lung AI-assisted Diagnosis Solution Revenue by Product in 2024
11.5.6 BioMind Lung AI-assisted Diagnosis Solution Revenue by Application in 2024
11.5.7 BioMind Lung AI-assisted Diagnosis Solution Revenue by Geographic Area in 2024
11.5.8 BioMind Lung AI-assisted Diagnosis Solution SWOT Analysis
11.5.9 BioMind Recent Developments
11.6 Shukun
11.6.1 Shukun Corporation Information
11.6.2 Shukun Business Overview
11.6.3 Shukun Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.6.4 Shukun Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.6.5 Shukun Recent Developments
11.7 Infervision
11.7.1 Infervision Corporation Information
11.7.2 Infervision Business Overview
11.7.3 Infervision Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.7.4 Infervision Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.7.5 Infervision Recent Developments
11.8 Deepwise
11.8.1 Deepwise Corporation Information
11.8.2 Deepwise Business Overview
11.8.3 Deepwise Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.8.4 Deepwise Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.8.5 Deepwise Recent Developments
11.9 Optellum
11.9.1 Optellum Corporation Information
11.9.2 Optellum Business Overview
11.9.3 Optellum Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.9.4 Optellum Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.9.5 Optellum Recent Developments
11.10 IMLINCS
11.10.1 IMLINCS Corporation Information
11.10.2 IMLINCS Business Overview
11.10.3 IMLINCS Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.10.4 IMLINCS Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 NeuMiva
11.11.1 NeuMiva Corporation Information
11.11.2 NeuMiva Business Overview
11.11.3 NeuMiva Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.11.4 NeuMiva Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.11.5 NeuMiva Recent Developments
11.12 VoxelCloud
11.12.1 VoxelCloud Corporation Information
11.12.2 VoxelCloud Business Overview
11.12.3 VoxelCloud Lung AI-assisted Diagnosis Solution Product Features and Attributes
11.12.4 VoxelCloud Lung AI-assisted Diagnosis Solution Revenue and Gross Margin (2020-2025)
11.12.5 VoxelCloud Recent Developments
12 Lung AI-assisted Diagnosis SolutionIndustry Chain Analysis
12.1 Lung AI-assisted Diagnosis Solution Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Lung AI-assisted Diagnosis Solution Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Lung AI-assisted Diagnosis Solution Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Sense Time
United-imaging
Huiying Medical
Yizhun
BioMind
Shukun
Infervision
Deepwise
Optellum
IMLINCS
NeuMiva
VoxelCloud
List of Tables
 Table 1. Global Lung AI-assisted Diagnosis Solution Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Lung AI-assisted Diagnosis Solution Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Lung AI-assisted Diagnosis Solution Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Lung AI-assisted Diagnosis Solution Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Lung AI-assisted Diagnosis Solution Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Lung AI-assisted Diagnosis Solution Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Lung AI-assisted Diagnosis Solution Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Lung AI-assisted Diagnosis Solution by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung AI-assisted Diagnosis Solution as of 2024)
 Table 11. Global Lung AI-assisted Diagnosis Solution Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Lung AI-assisted Diagnosis Solution Companies Headquarters
 Table 13. Global Lung AI-assisted Diagnosis Solution Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Lung AI-assisted Diagnosis Solution Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Lung AI-assisted Diagnosis Solution Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Lung AI-assisted Diagnosis Solution Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Lung AI-assisted Diagnosis Solution Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Lung AI-assisted Diagnosis Solution High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Lung AI-assisted Diagnosis Solution Growth Accelerators and Market Barriers
 Table 25. North America Lung AI-assisted Diagnosis Solution Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Lung AI-assisted Diagnosis Solution Growth Accelerators and Market Barriers
 Table 27. Europe Lung AI-assisted Diagnosis Solution Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Lung AI-assisted Diagnosis Solution Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Lung AI-assisted Diagnosis Solution Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Lung AI-assisted Diagnosis Solution Investment Opportunities and Key Challenges
 Table 31. Central and South America Lung AI-assisted Diagnosis Solution Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Lung AI-assisted Diagnosis Solution Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Lung AI-assisted Diagnosis Solution Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Sense Time Corporation Information
 Table 35. Sense Time Description and Major Businesses
 Table 36. Sense Time Product Features and Attributes
 Table 37. Sense Time Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Sense Time Revenue Proportion by Product in 2024
 Table 39. Sense Time Revenue Proportion by Application in 2024
 Table 40. Sense Time Revenue Proportion by Geographic Area in 2024
 Table 41. Sense Time Lung AI-assisted Diagnosis Solution SWOT Analysis
 Table 42. Sense Time Recent Developments
 Table 43. United Imaging Corporation Information
 Table 44. United Imaging Description and Major Businesses
 Table 45. United Imaging Product Features and Attributes
 Table 46. United Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. United Imaging Revenue Proportion by Product in 2024
 Table 48. United Imaging Revenue Proportion by Application in 2024
 Table 49. United Imaging Revenue Proportion by Geographic Area in 2024
 Table 50. United Imaging Lung AI-assisted Diagnosis Solution SWOT Analysis
 Table 51. United Imaging Recent Developments
 Table 52. Huiying Medical Corporation Information
 Table 53. Huiying Medical Description and Major Businesses
 Table 54. Huiying Medical Product Features and Attributes
 Table 55. Huiying Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Huiying Medical Revenue Proportion by Product in 2024
 Table 57. Huiying Medical Revenue Proportion by Application in 2024
 Table 58. Huiying Medical Revenue Proportion by Geographic Area in 2024
 Table 59. Huiying Medical Lung AI-assisted Diagnosis Solution SWOT Analysis
 Table 60. Huiying Medical Recent Developments
 Table 61. Yizhun Corporation Information
 Table 62. Yizhun Description and Major Businesses
 Table 63. Yizhun Product Features and Attributes
 Table 64. Yizhun Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Yizhun Revenue Proportion by Product in 2024
 Table 66. Yizhun Revenue Proportion by Application in 2024
 Table 67. Yizhun Revenue Proportion by Geographic Area in 2024
 Table 68. Yizhun Lung AI-assisted Diagnosis Solution SWOT Analysis
 Table 69. Yizhun Recent Developments
 Table 70. BioMind Corporation Information
 Table 71. BioMind Description and Major Businesses
 Table 72. BioMind Product Features and Attributes
 Table 73. BioMind Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. BioMind Revenue Proportion by Product in 2024
 Table 75. BioMind Revenue Proportion by Application in 2024
 Table 76. BioMind Revenue Proportion by Geographic Area in 2024
 Table 77. BioMind Lung AI-assisted Diagnosis Solution SWOT Analysis
 Table 78. BioMind Recent Developments
 Table 79. Shukun Corporation Information
 Table 80. Shukun Description and Major Businesses
 Table 81. Shukun Product Features and Attributes
 Table 82. Shukun Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Shukun Recent Developments
 Table 84. Infervision Corporation Information
 Table 85. Infervision Description and Major Businesses
 Table 86. Infervision Product Features and Attributes
 Table 87. Infervision Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Infervision Recent Developments
 Table 89. Deepwise Corporation Information
 Table 90. Deepwise Description and Major Businesses
 Table 91. Deepwise Product Features and Attributes
 Table 92. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Deepwise Recent Developments
 Table 94. Optellum Corporation Information
 Table 95. Optellum Description and Major Businesses
 Table 96. Optellum Product Features and Attributes
 Table 97. Optellum Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Optellum Recent Developments
 Table 99. IMLINCS Corporation Information
 Table 100. IMLINCS Description and Major Businesses
 Table 101. IMLINCS Product Features and Attributes
 Table 102. IMLINCS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. IMLINCS Recent Developments
 Table 104. NeuMiva Corporation Information
 Table 105. NeuMiva Description and Major Businesses
 Table 106. NeuMiva Product Features and Attributes
 Table 107. NeuMiva Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. NeuMiva Recent Developments
 Table 109. VoxelCloud Corporation Information
 Table 110. VoxelCloud Description and Major Businesses
 Table 111. VoxelCloud Product Features and Attributes
 Table 112. VoxelCloud Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. VoxelCloud Recent Developments
 Table 114. Raw Materials Key Suppliers
 Table 115. Distributors List
 Table 116. Market Trends and Market Evolution
 Table 117. Market Drivers and Opportunities
 Table 118. Market Challenges, Risks, and Restraints
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources


List of Figures
 Figure 1. Lung AI-assisted Diagnosis Solution Product Picture
 Figure 2. Global Lung AI-assisted Diagnosis Solution Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Public Cloud Product Picture
 Figure 4. Private Cloud Product Picture
 Figure 5. Global Lung AI-assisted Diagnosis Solution Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Clinic
 Figure 8. Imaging Center
 Figure 9. Lung AI-assisted Diagnosis Solution Report Years Considered
 Figure 10. Global Lung AI-assisted Diagnosis Solution Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Lung AI-assisted Diagnosis Solution Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Lung AI-assisted Diagnosis Solution Revenue Market Share by Region (2020-2031)
 Figure 14. Global Lung AI-assisted Diagnosis Solution Revenue Market Share Ranking (2024)
 Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 16. Public Cloud Revenue Market Share by Player in 2024
 Figure 17. Private Cloud Revenue Market Share by Player in 2024
 Figure 18. Global Lung AI-assisted Diagnosis Solution Revenue Market Share by Type (2020-2031)
 Figure 19. Global Lung AI-assisted Diagnosis Solution Revenue Market Share by Application (2020-2031)
 Figure 20. North America Lung AI-assisted Diagnosis Solution Revenue YoY (2020-2031) & (US$ Million)
 Figure 21. North America Top 5 Players Lung AI-assisted Diagnosis Solution Revenue (US$ Million) in 2024
 Figure 22. North America Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Type (2020 - 2031)
 Figure 23. North America Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Application (2020-2031)
 Figure 24. US Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 25. Canada Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 26. Mexico Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 27. Europe Lung AI-assisted Diagnosis Solution Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. Europe Top 5 Players Lung AI-assisted Diagnosis Solution Revenue (US$ Million) in 2024
 Figure 29. Europe Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Type (2020-2031)
 Figure 30. Europe Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Application (2020-2031)
 Figure 31. Germany Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 32. France Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 33. U.K. Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 34. Italy Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 35. Russia Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Lung AI-assisted Diagnosis Solution Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Top 8 Players Lung AI-assisted Diagnosis Solution Revenue (US$ Million) in 2024
 Figure 38. Asia-Pacific Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Type (2020-2031)
 Figure 39. Asia-Pacific Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Application (2020-2031)
 Figure 40. Indonesia Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 41. Japan Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 42. South Korea Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 43. Australia Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 44. India Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 45. Indonesia Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 46. Vietnam Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 47. Malaysia Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 48. Philippines Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 49. Singapore Lung AI-assisted Diagnosis Solution Revenue (2020-2031) & (US$ Million)
 Figure 50. Central and South America Lung AI-assisted Diagnosis Solution Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Central and South America Top 5 Players Lung AI-assisted Diagnosis Solution Revenue (US$ Million) in 2024
 Figure 52. Central and South America Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Type (2020-2031)
 Figure 53. Central and South America Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Brazil Lung AI-assisted Diagnosis Solution Revenue (2020-2025) & (US$ Million)
 Figure 55. Argentina Lung AI-assisted Diagnosis Solution Revenue (2020-2025) & (US$ Million)
 Figure 56. Middle East and Africa Lung AI-assisted Diagnosis Solution Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Middle East and Africa Top 5 Players Lung AI-assisted Diagnosis Solution Revenue (US$ Million) in 2024
 Figure 58. South America Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Middle East and Africa Lung AI-assisted Diagnosis Solution Revenue (US$ Million) by Application (2020-2031)
 Figure 60. GCC Countries Lung AI-assisted Diagnosis Solution Revenue (2020-2025) & (US$ Million)
 Figure 61. Israel Lung AI-assisted Diagnosis Solution Revenue (2020-2025) & (US$ Million)
 Figure 62. Egypt Lung AI-assisted Diagnosis Solution Revenue (2020-2025) & (US$ Million)
 Figure 63. South Africa Lung AI-assisted Diagnosis Solution Revenue (2020-2025) & (US$ Million)
 Figure 64. Lung AI-assisted Diagnosis Solution Industry Chain Mapping
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Lung AI assisted Diagnosis Software Market Research Report 2024
Global Medical AI assisted Diagnosis Solution Market Research Report 2024
Global AI Lung Screening System Market Research Report 2024
Global Breast AI assisted Diagnosis Solution Market Research Report 2024
Global Brain AI assisted Diagnosis Solution Market Research Report 2024
Global Cardiac AI assisted Diagnosis Solution Market Research Report 2024
Global Medical AI assisted Diagnosis Market Research Report 2024
Global Medical AI assisted Diagnosis Product Market Research Report 2024
Global Ophthalmic AI assisted Diagnosis Solution Market Research Report 2024
Global Artificial Intelligence Lung Screening System Market Research Report 2024
Global Breast AI assisted Diagnosis Market Research Report 2024
Global Interventional Lung Solutions Market Research Report 2024
Global Liver AI assisted Diagnosis Solution Market Research Report 2024
Global Brain AI assisted Diagnosis Market Research Report 2024
Global Medical AI assisted Diagnosis Software Market Research Report 2024
Global Cardiac AI assisted Diagnosis Market Research Report 2024
Global Bone AI assisted Diagnosis Solution Market Research Report 2024
Global Breast AI assisted Diagnosis Software Market Research Report 2024
Global Brain AI assisted Diagnosis Software Market Research Report 2024
Global Ophthalmic AI assisted Diagnosis Market Research Report 2024

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions